First Wave BioPharma (FWBI)
(Delayed Data from NSDQ)
$2.74 USD
+0.01 (0.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.74 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-2.18 | -11.72% |
Earnings Summary
For their last quarter, First Wave BioPharma (FWBI) reported earnings of -$9.20 per share, beating the Zacks Consensus Estimate of $-12.40 per share. This reflects a positive earnings surprise of 25.81%. Look out for FWBI's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$2.18 per share, reflecting a year-over-year increase of 94.01%.
Earnings History
Price & Consensus
Zacks News for FWBI
First Wave BioPharma (FWBI) Upgraded to Buy: What Does It Mean for the Stock?
FWBI: What are Zacks experts saying now?
Zacks Private Portfolio Services